EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe

Giuseppe M.C. Rosano, Stefan D. Anker, Walter Marrocco, Andrew J.S. Coats

Clinical Trials and Regulatory Science in Cardiology · 2015

DOI: 10.1016/j.ctrsc.2015.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Giuseppe M.C. Rosano und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rosano, G. M., Anker, S. D., Marrocco, W., & Coats, A. J. (2015). Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.02.001

Vancouver

Rosano GM, Anker SD, Marrocco W, Coats AJ. Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe. Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.02.001

BibTeX
@article{Rosano2015,
  author = {Rosano, Giuseppe M.C. and Anker, Stefan D. and Marrocco, Walter and Coats, Andrew J.S.},
  title = {Adaptive licensing — A way forward in the approval process of new therapeutic agents in Europe},
  journal = {Clinical Trials and Regulatory Science in Cardiology},
  year = {2015},
  doi = {10.1016/j.ctrsc.2015.02.001}
}
Kostenlos starten →